RILA yields 0.12% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, RILA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RILA + JNJ for your $10,000?
RILA targets US stocks of any capitalization perceived to have growth potential. The fund considers equity securities from two growth indices representing all-cap and large-cap companies. Both indices select companies based on growth factor scores and solvency criteria. The fund seeks to build a portfolio with a 65% match to the all-cap index and 35% to the large-cap index. Target allocations may be adjusted based on the fund managers judgment and analysis of broad market conditions and individual securities. The fund considers interest rates, trading volume and market sentiment indicators, market trends and sectors, individual securities, and other financial data. Index reconstitution and rebalancing inform security selection. However, as an actively managed ETF, the fund manager can buy or sell securities as part of their review or at any time at their discretion.
Full RILA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.